CCR7 is highly expressed on B cells from CLL patients and mediates migration towards its ligands CCL19 and CCL21, while CRAM expression and potential interferences with CCR7 are yet to be characterized. This evidence concerns the gene CCL19 and B-cell chronic lymphocytic leukemia.